Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: Difficulties in the diagnosis

Zschocke, 2000, Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism, Pediatr. Res., 48, 852, 10.1203/00006450-200012000-00025 Yan, 1997, An intracellular protein that binds amyloid-b peptide and mediates neurotoxicity in Alzheimer's disease, Nature, 389, 689, 10.1038/39522 Lustbader, 2004, ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease, Science, 304, 448, 10.1126/science.1091230 Yang, 2005, Multiple functions of type 10 17β-hydroxysteroid dehydrogenase, Trends Endocrinol. Metab., 16, 167, 10.1016/j.tem.2005.03.006 Murakami, 2007, Cytoprotective role of mitochondrial amyloid β peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde, Neurobiol. Aging Poll-The, 2004, Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases, Mol. Genet. Metab., 81, 295, 10.1016/j.ymgme.2003.11.013 Ensenauer, 2002, Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency, Ann. Neurol., 51, 656, 10.1002/ana.10169 Olpin, 2002, 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23 year old man, J. Inherit. Metab. Dis., 25, 477, 10.1023/A:1021251202287 Sass, 2004, 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease, Brain Dev., 26, 12, 10.1016/S0387-7604(03)00071-8 Sutton, 2003, 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency, J. Inherit. Metab. Dis., 26, 69, 10.1023/A:1024083715568 Perez-Cerdá, 2005, 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease, Pediatr. Res., 58, 488, 10.1203/01.pdr.0000176916.94328.cd Cazorla, 2007, Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, Pediatr. Neurol., 36, 264, 10.1016/j.pediatrneurol.2006.11.014 Ofman, 2003, 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene, Am. J. Hum. Genet., 72, 1300, 10.1086/375116 Lenski, 2007, The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behaviour, Am. J. Hum. Genet., 80, 372, 10.1086/511527 Miller, 1998, Chromosomal basis of X chromosome inactivation: identification of a multigene domain in Xp11.21–p11.22 that escapes X inactivation, Genetics, 95, 8709 Ribes, 1992, Significance of bound glutarate in the diagnosis of glutaric aciduria type I, J. Inherit. Metab. Dis., 15, 367, 10.1007/BF02435978 Wanders, 2001, 2-methyl.3.hydroxybutyryl-CoA dehydrogenase deficiency, a new disorder of isoleucine and branched-chain fatty acid degradation: studies on the forward and reverse reactions, New Avenues of Research in Fatty Acid Oxidation and Ketone Body Metabolism, 59 Rosa, 2005, Inhibition of energy metabolism by 2-methylacetoacetate and 2-methy-3-hydroxybutyrate in cerebral cortex of developing rats, J. Inherit. Metab. Dis., 28, 501, 10.1007/s10545-005-0501-3 Mammer, 1976, Demonstration of a new mammalian isoleucine catabolic pathway yielding an R series o metabolites, Biochem. J., 160, 417, 10.1042/bj1600417a Chelly, 1986, De novo DNA microdeletion in a girl with Turner syndrome and Duchenne muscular dystrophy, Hum. Genet., 74, 193, 10.1007/BF00282093 Zschocke, 2007, Neurodegeneration in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency is unrelated to enzyme function, J. Inherit. Metab. Dis., 30, 42